foxo4-dri vs gdf-11 induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation GDF11 and aging biology -

Do peptides speed up ACL or knee replacement recovery

Clinical pen device: In trials, cagrilintide was delivered via Novo Nordisk's prefilled pen

Sugihara H, Moriyoshi K, Ishii T, Masu M, Nakanishi S

Li Q, Sun M, Wang M, Feng M, Yang F, Li L, Zhao J, Chang C, Dong H, Xie T, Chen J

2,3 REDEFINE 1 was a 68-week, double-blind, randomized, placebo- and active-controlled phase 3 trial that evaluated the efficacy and safety of once-weekly CagriSema versus cagrilintide 2.4 mg monotherapy, semaglutide 2.4 mg monotherapy, and placebo, all in combination with lifestyle intervention in 3,417 adults with obesity or overweight with one or more obesity-related complications and without type 2 diabetes